J. Lenaerts

发表

The hybridoma/plasmacytoma growth factor (HPGF) activity of IL-6. Stimulation of its secretion by different inducers in various cell types

G. Opdenakker, J. Snick, J. Damme, 1989 .

The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis

P. Geusens, P. Stinissen, J. Vanhoof, 2016, Arthritis Research & Therapy.

The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte‐derived interleukin 8

G. Opdenakker, A. Billiau, J. Damme, 1989, European journal of immunology.

Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.

Ji Ming Wang, P. Proost, A. Ben-Baruch, 1998, European journal of biochemistry.

The CXC Chemokine GCP-2/CXCL6 Is Predominantly Induced in Mesenchymal Cells by Interleukin-1β and Is Down-Regulated by Interferon-γ: Comparison with Interleukin-8/CXCL8

G. Opdenakker, P. Proost, K. Geboes, 2003, Laboratory Investigation.

Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family

G. Opdenakker, P. Proost, J. Van Damme, 1992, The Journal of experimental medicine.

Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.

P. Geusens, S. Boonen, D. Vanderschueren, 2002, The Journal of clinical endocrinology and metabolism.

Purification and characterization of human fibroblast-derived hybridoma growth factor identical to T-cell-derived B-cell stimulatory factor-2 (interleukin-6).

R. Simpson, J. Snick, J. Van Snick, 1987, European journal of biochemistry.

Augment the In Vitro and In Vivo Neutrophil Murine Granulocyte Chemotactic Protein-2 NH2- and COOH-Terminal Truncations of

P. Proost, J. Lenaerts, A. D’Haese, 2013 .

Chemotactic Potency Augment the In Vitro and In Vivo Neutrophil Murine Granulocyte Chemotactic Protein-2-and COOH-Terminal Truncations of 2 NH Heremans

P. Proost, H. Heremans, A. Loof, 1999 .

Differential induction of monocyte chemotactic protein‐3 in mononuclear leukocytes and fibroblasts by interferon‐α / β and interferon‐γ reveals MCP‐3 heterogeneity

G. Opdenakker, A. Billiau, P. Proost, 1999 .

NH 2-and COOH-Terminal Truncations of Murine Granulocyte Chemotactic Protein-2 Augment the In Vitro and In Vivo Neutrophil Chemotactic Potency 1

P. Proost, H. Heremans, A. Loof, 1999 .

NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.

P. Proost, H. Heremans, J. Van Damme, 1999, Journal of immunology.

CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.

E. De Clercq, M. Parmentier, G. Opdenakker, 1999, Journal of immunology.

Isolation of the CXC chemokines ENA‐78, GROα and GROγ from tumor cells and leukocytes reveals NH2‐terminal heterogeneity

P. Proost, J. Damme, S. Struyf, 1999 .

CC Chemokine Receptor 3 Human Eotaxin by Affecting Its Interaction Potency , But Not the Anti-HIV Activity of Down-Regulates the Eosinophil Chemotactic CD 26 / Dipeptidyl-Peptidase IV

M. Parmentier, G. Opdenakker, P. Proost, 1999 .

Processing by CD26/dipeptidyl‐peptidase IV reduces the chemotactic and anti‐HIV‐1 activity of stromal‐cell‐derived factor‐1α

E. De Clercq, C. Durinx, P. Proost, 1998, FEBS letters.

Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.

Yeong-Wook Song, Sung-Hwan Park, L. Myasoutova, 2016, Rheumatology.

Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis.

P. Geusens, P. Stinissen, A. H. M. van der Helm-van Mil, 2016, Rheumatology.

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

P. Geusens, R. Westhovens, P. Verschueren, 2015, Arthritis Research & Therapy.

Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.

G. Opdenakker, P. Proost, H. Heremans, 1994, Journal of immunology.

Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form.

A. Billiau, J. Van Damme, B. Decock, 1990, Biochemical and biophysical research communications.

Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double‐stranded RNA or cytokine

A. Mantovani, A. Billiau, R. Bertini, 1989, European journal of immunology.

Production and identification of natural monocyte chemotactic protein from virally infected murine fibroblasts. Relationship with the product of the mouse competence (JE) gene.

A. Mantovani, G. Opdenakker, R. Bertini, 1991, European journal of biochemistry.

Natural Chemokine Inhibitor − MCP-2 ( 6 Proteins MCP-1 and MCP-2 : Identification of Activity of the Human Monocyte Chemotactic Posttranslational Modifications Affect the

P. Verhaert, P. Proost, J. Damme, 1998 .

Carcinoma cell-derived chemokines and their presence in oral fluid.

R. Jacobs, P. Proost, J. Van Damme, 2009, European journal of oral sciences.

Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor

Ji Ming Wang, P. Proost, I. De Meester, 1998, European journal of immunology.

Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.

P. Proost, J. Van Damme, S. Struyf, 1999, European journal of biochemistry.

Purification, sequence analysis, and biological characterization of a second bovine monocyte chemotactic protein-1 (Bo MCP-1B).

P. Proost, J. Van Damme, A. Wuyts, 1994, Biochemistry.

Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.

P. Geusens, S. Boonen, D. Vanderschueren, 2002, The Journal of clinical endocrinology and metabolism.

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

P. Geusens, R. Westhovens, P. Verschueren, 2016, Annals of the rheumatic diseases.

lymphocytes as a novel CC chemokine, Regakine-1 Identification of a blood-derived chemoattractant for neutrophils and

P. Proost, J. Damme, S. Struyf, 2013 .

Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1.

P. Proost, J. Van Damme, S. Struyf, 2001, Blood.

Monocyte chemotactic proteins related to human MCP-1.

G. Opdenakker, P. Proost, J. Van Damme, 1993, Advances in experimental medicine and biology.

Human and bovine granulocyte chemotactic protein-2: complete amino acid sequence and functional characterization as chemokines.

G. Opdenakker, P. Proost, J. Van Damme, 1993, Biochemistry.

The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice

A. Boonen, C. Ribbens, K. de Vlam, 2007, Annals of the rheumatic diseases.

Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes.

P. Proost, J. Van Damme, A. Wuyts, 1994, Journal of immunological methods.

Diverging binding capacities of natural LD78β isoforms of macrophage inflammatory protein‐1α to the CC chemokine receptors 1, 3 and 5 affect their anti‐HIV‐1 activity and chemotactic potencies for neutrophils and eosinophils

Dominique Schols, Paul Proost, E. De Clercq, 2001, European journal of immunology.

Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.

P. Verhaert, P. Proost, J. Van Damme, 1998, Journal of immunology.

new dimension of immunoregulation naturally occurring posttranslational modification of chemokines and Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a

P. Proost, A. Mortier, Van Damme, 2013 .

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.

P. Proost, J. Van Damme, A. Mortier, 2008, Blood.

Synergistic induction of MCP‐1 and ‐2 by IL‐1β and interferons in fibroblasts and epithelial cells

G. Opdenakker, P. Proost, J. Damme, 1998, Journal of leukocyte biology.

Regulated Production and Molecular Diversity of Human Liver and Activation-Regulated Chemokine/Macrophage Inflammatory Protein-3α from Normal and Transformed Cells1

P. Proost, J. Van Damme, E. Schutyser, 2000, The Journal of Immunology.

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

M. Dougados, D. M. van der Heijde, A. Boonen, 2021, Annals of the Rheumatic Diseases.

Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome

A. Boonen, C. Ribbens, K. de Vlam, 2009, The Journal of Rheumatology.

Clinical Characteristics and Functional Outcome Spinal Radiographic Changes in Ankylosing Spondylitis : Association with DEWULF

C. Ribbens, S. Steinfeld, N. Vastesaeger, 2009 .

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

V. Mazurov, J. Lenaerts, L. Myasoutova, 2013, Annals of the rheumatic diseases.

Effects of Long‐Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104‐Week Results From a Randomized, Placebo‐Controlled Study

M. Dougados, D. M. van der Heijde, I. Logeart, 2017, Arthritis care & research.

Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2.

G. Opdenakker, P. Proost, J. Van Damme, 1996, Journal of immunology.

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

P. Geusens, R. Westhovens, P. Verschueren, 2014, Annals of the rheumatic diseases.

THU0274 Double-blind, placebo-controlled, 28-week trial of efficacy and safety of infliximab plus naproxen vs naproxen alone in patients with early, active axial spondyloarthritis treated with a submaximal dose of NSAIDS: Preliminary results of INFAST part I

V. Mazurov, L. Myasoutova, J. Sieper, 2013 .

Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2

V. Mazurov, J. Lenaerts, L. Myasoutova, 2013, Annals of the rheumatic diseases.

Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants.

G. Opdenakker, P. Proost, J. Van Damme, 2001, Biochemistry.

Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity.

G. Opdenakker, A. Billiau, P. Proost, 1999, European journal of immunology.

Agreement between evidence and Belgian rheumatologists' experience on the use of DMARDs for arthritis and/or enthesitis in ankylosing spondylitis

H. Mielants, F. Bosch, J. Lenaerts, 2008 .

Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis

L. Corluy, D. Elewaut, R. Colman, 2018, Arthritis & rheumatology.

Interleukin 1 induces different cytokines in human fibroblasts.

J. Van Damme, A. Billiau, W. Put, 1989, Lymphokine research.

Assays for leucocyte migration

J. Damme, S. Struyf, J. Lenaerts, 2000 .